A
ATX
AMPLIA THERAPEUTICS
0.12
-0.01-4.00%Closed16:10 02/06 AEDT
OPEN/PREV CLOSE0.122/0.125
TODAY RANGE0.110-0.123
VOL1.91M
MARKET CAP61.57M
52 WEEK RANGE0.049-0.425
AVG VOL (3M)992.03K
% TURNOVER0.37%
TURNOVER225.39K
P/E (TTM)-5.8824
% RANGE10.00%
EPS(TTM)-0.0204
P/E(FORWARD)--
P/B1.434
BVPS0.084
DIVIDEND--
P/S12.37
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP52.19M
SHARES OUTSTANDING513.07M
NEXT EARNINGS05/28-06/01
FREE FLOAT434.91M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/30 00:00
AMPLIA THERAPEUTICS LIMITED Prelim Q4
ASX·01/22 05:46
Change in substantial holding
ASX·01/21 21:22
Narmafotinib Large-Scale Manufacture Complete
ASX·01/09 05:22
ACCENT Data Presented at 2026 ASCO GI Cancer Symposium
ASX·12/18/2025 21:27
Amplia Enters 2nd Agreement with Drug Screening Co Next Bio
ASX·12/11/2025 08:58
Additional Confirmed Response Reported-Investor Presentation
ASX·12/04/2025 00:00
AMPLIA THERAPEUTICS LIMITED Prelim Q2
ASX·12/02/2025 21:32
Key narmafotinib Patent Granted in the US
ASX·11/27/2025 05:45
Half Yearly Report and Accounts
ASX·11/19/2025 17:01
Positive Response from US FDA to Amplia's Type D Meeting
ASX·11/10/2025 05:42
Notification regarding unquoted securities - ATX
ASX·10/30/2025 21:19
Amplia Commences Trading on U.S. OTCQB Venture Market
ASX·10/28/2025 22:05
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·10/27/2025 22:15
Amplia Receives R&D Tax Rebate Totalling $3.77 Million
ASX·10/16/2025 23:35
Amplia Therapeutics to Significantly Expand U.S. Presence
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others